MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Thursday, November 30, 2017

New findings uncover the mechanisms by which gut bacteria can trigger inflammation in the brain and contribute to multiple sclerosis


New findings uncover the mechanisms by which gut bacteria can trigger inflammation in the brain and contribute to multiple sclerosis

Suhayl Dhib-Jalbut, M.D., to present findings in keynote address at ACTRIMS Forum 2018

Madison, Wis., Nov. 30, 2017 – A breakthrough in the understanding of how altered gut bacteria breaks immune tolerance towards the brain, and how this can trigger the immune system to attack brain tissue, will be presented as the subject of the keynote Kenneth P. Johnson Memorial Lecture on the opening day of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2018.

ACTRIMS Forum 2018 will take place Feb. 1-3, in San Diego, California, U.S.

An altered gut microbiota, known as dysbiosis, is often observed in patients with multiple sclerosis (MS), but it has not been clear how this contributes to the onset or progression of the disease. New research, conducted by Suhayl Dhib-Jalbut, M.D., Sudhir Yadav, Ph.D. and Kouichi Ito, Ph.D., all investigators at the Rutgers-Robert Wood Johnson Center for Multiple Sclerosis, provides evidence that dysbiosis stimulates the development of pathogenic T cells in mice, thereby initiating or exacerbating an animal model of MS.

This discovery has potential therapeutic implications in MS by manipulating the composition of gut bacteria, according to study researcher Dhib-Jalbut, who will present the findings of the team’s research.

Furthermore, “the findings could have potential implications on other autoimmune diseases above and beyond MS,” says Dhib-Jalbut.

The late Kenneth P. Johnson, M.D., University of Maryland, led the effort to found ACTRIMS in 1996. The Memorial Lecture honors Johnson by providing an opportunity for ACTRIMS audiences to hear from prestigious clinicians or researchers selected for their knowledge, accomplishments and contributions related to MS.

ACTRIMS Forum brings together researchers and clinicians to share developments in the rapidly changing field of MS. More information about ACTRIMS Forum 2018, and the Kenneth P. Johnson Memorial Lecture appears on the event’s website at

# # #


No comments: